Navigation Links
BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009

PLYMOUTH MEETING, Pa., Jan. 12 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced that senior executives voluntarily elected certain compensation restrictions in the fiscal years 2008 and 2009. Senior executives rescinded any 2008 bonus payments, and elected to not increase executive salaries while also reducing stock option compensation for 2009. In addition, the Board of Directors voluntarily reduced their stock option compensation for 2009. After consideration of BMP Sunstone's many achievements during 2008 and management's commitment to the Company, this offer was approved by the Compensation Committee of the Board of Directors.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "The year 2008 was a turning point for our Company as we achieved record top and bottom-line financial performance, completed transformative acquisitions with Sunstone and Rongheng, solidified our presence in China's top three pharmaceutical markets of Beijing, Shanghai and Guangzhou, diversified our product offering with exciting new product launches and product approvals, and strengthened our management team across the organization. Despite the Company's significant progress during 2008, the board and management team have decided to take these compensation restrictions in recognition of the current global economic environment. The success achieved in 2008 enables us to enter 2009 in a strong competitive position and to continue growing our business. We remain enthusiastic about the business prospects in China's rapidly growing healthcare sector."

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit .

SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Receives High Tech Status
2. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
3. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
4. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
5. BMP Sunstone Reports Third Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in November Investor Conferences
7. BMP Sunstone Announces Participation in September Investor Conference
8. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
9. BMP Sunstone Reports Second Quarter 2008 Financial Results
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. BMP Sunstone Receives Import Drug License (IDL) from SFDA
Post Your Comments:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... June 23, 2016 ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... . The Global Cell ...
Breaking Biology Technology:
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):